Sensex
77,550.25 profit arw 918.60 (1.20%)
Nifty
24,050.60 profit arw 275.50 (1.16%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
IPO

IPO Details


Sai Parenteral's Ltd
Registered Office: No.39 5th Flr Lavanya Arcade-, Jayabheri Enclave Gachibowli, Ranga Reddy - 500032, Telangana
Phone: +91 79979 91301
Email: cs@saiparenterals.com
Website: https://www.saiparenterals.com
Initial public offer of 10,428,288 equity shares of face value of Rs. 5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs. 392 per equity share (Including a Share Premium of Rs. 387 Per Equity Share) ("Offer Price") aggregating to Rs. 408.79 Crore comprising a fresh issue of 7,270,408 equity shares of face value of Rs. 5 each aggregating to Rs. 285 Crore by the company ("Fresh Issue") and an offer for sale of 3,157,880 equity shares of face value of Rs. 5 each aggregating to Rs. 123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute 23.60% of the post-offer paid up equity share capital of the company. Price Band: Rs. 392 per equity share of face value of Rs. 5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs. 5 each and in multiples of 38 equity shares of face value of Rs. 5 each thereafter.
Issue Money Payable On
Opens On Closes On Application Allotment
24-Mar-2026 27-Mar-2026 ₹ 392.00 ₹ 0.00
Minimum Application for shares in Nos : 38.0 Further Multiples of : 38.0
(₹)Cr. Lead Managers to the Issue
Project Cost 256.50 Arihant Capital Markets Limited
Project Financed through Current Offer 408.79
Post Issue Equity Share Capital 22.09
Issue Price ₹392.00
Projects
Capacity expansion and upgradation of manufacturing facilities
Establishment of a new R&D Centre
Repayment / prepayment of certain outstanding borrowings
Working capital requirements
Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
General corporate purposes
Promoted By
Anil Kumar Karusala
Vijitha Gorrepati
Karusala Aruna
Listing At
BSE
NSE
Registrar to the Issue

INDIAN INDICES

Sensex

77,550.25 918.60 (1.20%)

Nifty

24,050.60 275.50 (1.16%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

25,893.55 141.14(0.55%)